Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved "backdoor" cysteine

被引:0
|
作者
Yarnall, Matthew T. N. [1 ]
Kim, Sean H. [1 ]
Korntner, Samuel [1 ]
Bishop, Anthony C. [1 ]
机构
[1] Amherst Coll, Dept Chem, Amherst, MA 01002 USA
基金
美国国家卫生研究院;
关键词
Protein tyrosine phosphatases; Backdoor cysteines; SHP1; SHP2; PTP1B; Protein stability; REDOX REGULATION; ALLOSTERIC SITE; MUTATIONS; INHIBITION; PTPN11;
D O I
10.1016/j.bbrep.2022.101370
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein tyrosine phosphatases (PTPs) are critical regulators of cellular signal transduction that catalyze the hydrolytic dephosphorylation of phosphotyrosine in substrate proteins. Among several conserved features in classical PTP domains are an active-site cysteine residue that is necessary for catalysis and a "backdoor" cysteine residue that can serve to protect the active-site cysteine from irreversible oxidation. Curiously, two biologically important phosphatases, Src homology domain-containing PTPs 2 and 1 (SHP2 and SHP1), each contain an additional backdoor cysteine residue at a position of the PTP domain that is occupied by proline in almost all other classical PTPs (position 333 in human SHP2 numbering). Here we show that the presence of cysteine 333 significantly destabilizes the fold of the PTP domains in the SHPs. We find that replacement of cysteine 333 with proline confers increased thermal stability on the SHP2 and SHP1 PTP domains, as measured by temperature -dependent activity assays and differential scanning fluorimetry. Conversely, we show that substantial destabi-lization of the PTP-domain fold is conferred by introduction of a non-natural cysteine residue in a non-SHP PTP that contains proline at the 333 position. It has previously been suggested that the extra backdoor cysteine of the SHP PTPs may work in tandem with the conserved backdoor cysteine to provide protection from irreversible oxidative enzyme inactivation. If so, our current results suggest that, during the course of mammalian evolution, the SHP proteins have developed extra protection from oxidation at the cost of the thermal instability that is conferred by the presence of their PTP domains' second backdoor cysteine.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
    Buck, Sara J. S.
    Plaman, Bailey A.
    Bishop, Anthony C.
    ACS OMEGA, 2022, 7 (16): : 14180 - 14188
  • [2] Targeting non-conserved cysteines for allosteric inhibition of SHP2
    Kao, Lynn
    Kim, Jenny
    Bishop, Anthony
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [3] The role of the protein tyrosine phosphatase SHP2 in ossification
    Zhang, Yuan
    Lu, Wei
    Zhao, Qing
    Chen, Jindong
    Wang, Tiancong
    Ji, Jun
    DEVELOPMENTAL DYNAMICS, 2022, 251 (05) : 748 - 758
  • [4] The Landscape of Protein Tyrosine Phosphatase (Shp2) and Cancer
    Rehman, Ashfaq Ur
    Rahman, Mueed Ur
    Khan, Muhammad T.
    Saud, Shah
    Liu, Hao
    Song, Dong
    Sultana, Pinky
    Wadood, Abdul
    Chen, Hai-Feng
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (32) : 3767 - 3777
  • [5] Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development
    Kuo, Emory
    Park, Daniel K.
    Tzvetanova, Iva D.
    Leiton, Cindy V.
    Cho, Brian S.
    Colognato, Holly
    JOURNAL OF NEUROCHEMISTRY, 2010, 113 (01) : 200 - 212
  • [6] Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
    Chen, Chuan
    Cao, Mengmeng
    Zhu, Siyu
    Wang, Cuicui
    Liang, Fan
    Yan, Leilei
    Luo, Duqiang
    SCIENTIFIC REPORTS, 2015, 5
  • [7] Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2
    Chuan Chen
    Mengmeng Cao
    Siyu Zhu
    Cuicui Wang
    Fan Liang
    Leilei Yan
    Duqiang Luo
    Scientific Reports, 5
  • [8] Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
    Chen, Liwei
    Sung, Shen-Shu
    Yip, M. L. Richard
    Lawrence, Harshani R.
    Ren, Yuan
    Guida, Wayne C.
    Sebti, Said M.
    Lawrence, Nicholas J.
    Wu, Jie
    MOLECULAR PHARMACOLOGY, 2006, 70 (02) : 562 - 570
  • [9] Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention
    Butterworth, Sam
    Overduin, Michael
    Barr, Alastair J.
    FUTURE MEDICINAL CHEMISTRY, 2014, 6 (12) : 1423 - 1437
  • [10] Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1
    Hennige, AM
    Lammers, R
    Höppner, W
    Arlt, D
    Strack, V
    Teichmann, R
    Machicao, F
    Ullrich, A
    Häring, HU
    Kellerer, M
    ENDOCRINOLOGY, 2001, 142 (10) : 4441 - 4447